Fluorescence and site-directed mutagenesis studied of interleukin 1β

Cytokine

Volumn 9, Issue 3, 1997, Pages 149-156

  Epps, D E ^a   Yem, A W ^a   McGee, J M ^a   Tomich, C S C ^a   Curry, K A ^a   Chosay, J G ^a   Deibel, M R ^a  

^a PFIZER INC   (United States)

Author keywords

Fluorescence; Interleukin 1 ; Site directed mutagenesis

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MUTANT PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; FLUORESCENCE ANALYSIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FOLDING; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

EID: 0031104856     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0149     Document Type: Article

References (33)

1. 1. Dinarello CA (1991) Modalities for reducing interleukin 1 activity in disease. Blood 77:1627-1652.
2. 2. Dinarello CA (1993) Interleukin-1 and interleukin-1 antagonism. Immunol Today 14:260-264.
3. 3. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KHDower SK (1993) cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Proc Nat Acad Sci USA 90:6155-6159.
4. 4. Kilian PJ, Kaffka KL, Stern AS, Woehle D, Benjamin WR, Dechiara TM, Gubler U, Farrar JJ, Mizel SB, Lowmedico PT (1986) Interleukin 1α and interleukin 1β bind to the same receptor on T cells. J Immunology 36:4509-4514.
5. 5. Evans RJ, Bray J, Childs JD, Vigers GPA, Brandhuber BJ, Skalicky JJ, Thompson RC, Eisenberg SP (1995) Mapping receptor binding sites in interleukin-1 receptor antagonist and IL-1β by site-directed mutagenesis. J Biol Chem 270:11477-11483.
6. 6. Labriola-Tompkins E, Chandran C, Kaffka KL, Biondi D, Graves BJ, Hatada M, Madison VS, Karas J, Kilian PJ, Ju G (1991) Identification of the Discontinuous binding site in human interleukin 1β for the type I interleukin 1 receptor. Proc Natl Acad Sci USA 88:11182-11186.
7. 7. Clora GM, Wingfield PT, Gronenborn AM (1991) High resolution three dimensional structure of IL-1β in solution by 3D and 4D NMR. Biochemistry 30:2315-2323.
8. 8. Stockman BJ, Scahill TA, f Strakalaitis NA, Brunner DP, Yem AW, Deibel MR (1992) Proton, carbon, and nitrogen chemical shifts accurately delineate differences and similarities in secondary structure between homologous proteins IRAP and IL-1β. J Biomol. NMR 2:591-596.
9. 1H NMR spectroscopy. Biochemistry 29:4668-4682.
10. 1H-NMR study of interleukin-1β. Eur J Biochem 14:37-43.
11. 11. Craig S, Pain RH, Schmeissner U, Virden R, Wingfield PT (1989) Determination of the contributions of individual aromatic residues to the CD spectrum of IL-1β using site-directed mutagenesis. Int J Pept Prot Res 1989 33:256-262.
12. 12. Gilliland GL, Winborne EL, Masui Y, Harai Y (1987) A preliminary crystallographic study of recombinant human interleukin-1β. J Biol Chem 262:12323-12324.
13. 13. Finzel BC, Clancy LL, Holland DR, Muchmore SW, Watenpaugh KD, Einspahr HM (1989) Crystal structure of recombinant interleukin-1β at 2 Å resolution. J Mol Biol 209:779-791.
14. 14. Carter DB, Curry KA, Tomich C-SC, Yem AW, Deibel MR, Tracey DE, Paslay JW, Carter JB, Theriault NY, Harris PKW, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Clancy LL, Muchmore SW, Watenpaugh KD, Einspahr, HM (1988) Crystallization of purified recombinant interleukin-1β. Proteins: structure function genetics 3:121-129.
15. 15. Veerapandian B, Gilliland GL, Raag R, Svensson AL, Masui Y, Hirai Y, Poulos TL (1992) Functional implications of interleukin-1β based on the three-dimensional structure. Proteins. Structure, Function, Genetics 12:10-23.
16. 16. Yem AW, Zurcher-Neely HA, Richard KA, Staite ND, Heinrikson RL, Deibel MR Jr (1989) Biotinylation of reactive amino groups in native recombinant human Interleukin-1β. J Biol Chem 264:17691-17697.
17. 17. Yem AW, Epps DE, Mathews WR, Guido DM, Richard KA, Staite ND, Deibel MR Jr (1992) Site-specific chemical modification of interleukin-1β by acrylodan at cysteine 8 and lysine 103. J Biol Chem 267:3122-3128.
18. 18. Epps DE, Yem AW, Fisher JF, McGee JE, Paslay JW, Deibel MR Jr (1992) Spectral characterization of environment-sensitive adducts of interleukin-1β. J Biol Chem 267:3129-3135.
19. 19. Yem AW, Guido DM, Mathews WR, Staite ND, Richard KA, Prairie MD, Krueger WC, Epps DE, Deibel MR Jr (1992) Chemical modification of interleukin-1β: biochemical characterization of a carbodiimide-catalyzed intramolecular cross-linked protein. J Protein Chem 11:709-722.
20. 20. Auron PE, Quigley GL, Rosenwasser LJ, Gehrke L. (1992) Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1β. Protein Biochem 31:6632-6638.
21. 21. Boraschi D, Bossu P, Ruggiero P, Tagliabue A, Bertini R, Macchia G, Gasborro C, Pellegrini L, Melillo G, Ulisse E, Visconti U, Bizzarri C, Del Grosso E, Mackay AR, Frascotti G, Frigerio F, Grifantini R, Grandi G (1988) In vivo stimulation of the immune response by the noninflammatory fragment 163-171 of human interleukin 1β. J Exp Med 168:675-686.
22. 22. Epps DE, Yem AW, Deibel MR (1989) Characterization of the tryptophan environments of interleukins 1α and 1β by fluorescence quenching and lifetime measurements. Arch Biochem Biophys 275:82-91.
23. 23. Craig S, Schmeissner U, Wingfield P, Pain RH (1987) Conformation, stability, and folding of interleukin-1β. Biochemistry 26:3570-3576.
24. 24. Wolfson AJ, Kanaoka M, Lau F, Ringe D (1993) Modularity of Protein function: chimeric interleukin-1βs containing specific protease inhibitor loops retain function of both molecules. Biochemistry 32:5327-5331.
25. 25. Simoncits A, Bristulf J, Tjornhammer ML, Cserzo M, Pongor S, Rybakina E, Gatti S, Bartfai T (1994) Deletion mutants of human interleukin 1β with significantly reduced agonist properties: Search for the agonist/antagonist switch in ligands to the interleukin receptors. Cytokine 6:206-214.
26. 26. Antoni G, Presentini R, Perin F, Tagliabue A, Ghiara P, Censini S, Volpini G, Villa L, Boraschi D (1986) A short synthetic peptide fragment of interleuiin 1 with immunostimulatory but not inflammatory activity. J Immunol 137:3201-3204.
27. 27. Frasca D, Boraschi D, Bachieri S, Bossu P, Tagliabue A, Adorini L, Doria G (1988) In vivo restoration of T cell functions by human IL-1β or its 163-171 nonapeptide in immunodepressed mice. J Immunol 141:2651-2655.
28. 28. Guinet F, Guitton J-D, Gault N, Folliard F, Touchet N, Cherel J-M, Chespo A, Destourbe A, Bertrand P, Denefle P, Mayaux J-F, Bousseau A, Duchesne M, Terlain B, Cartwright T (1993) J Biochem 211:583-590.
29. 29. Meyers CA, Johanson KO, Miles LM, McDevitt PJ, Simon PL, Webb RL, Chen M-Jy, Hoskin BP, Lillquist JS, Young PR (1987) Purification and characterization of human recombinant interleukin-1β. J Biol Chem 262:11176-11181.
30. 30. Marotti KR, Tomich C-SC (1989) Simple and efficient oligonucleotide-directed mutagenesis using one primer and circular plasmid DNA template. Gene Anal Technol 6:67-70.
31. 31. Yem AW, Curry KA, Tomich C-SC, Deibel MR Jr (1988) A two-step purification of recombinant human interleukin-1β. Expressed in E. coli. Immunol Invest 17:551-559.
32. 1. J Immunol 120:1497-1503.
33. 33. Gratton E, Jameson DM, Hall RD (1984) Multifrequency phase fluorometry. Annu Rev Biohys Bioeng 13:105-124.